Skip to content

Homeopathic treatment of sore throat

Effectiveness of Cistus canadensis vs. individualized homoeopathic medicines in the treatment of chronic tonsillitis in children: An open-label randomized pragmatic equivalence trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/10/016161
Enrollment
60
Registered
2018-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J350- Chronic tonsillitis and adenoiditis

Interventions

Intervention1: Cistus canadensis in centesimal or fifty millesmial potencies: It is planned as administering Cistus canadensis in centesimal or fifty millesmial potencies, as decided appropriate to th
dosage and repetition depending upon the individual requirement of the cases. In 50 millesimal scale, a single medicated cane sugar globules of poppy seed size (no.10) shall be dissolved in 90 ml of d
16 doses to be marked on the vial
each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the vial in 45 ml normal water in a clean cup, to stir well, to take 5 ml of this liquid orally on clean tongue with empty
dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP)certified firm. Duration of therapy: 3 months. Cont
dosage and repetition depending upon the individual requirement of the cases. In 50 millesimal scale, a single medicated cane sugar globules of poppy seed size (no.10) sha

Sponsors

National Institute Of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Cases presenting with clinical signs and symptoms of chronic tonsillitis 2. Age of 8-18 years 3. Both sexes 4. Presence of any symptoms of hyperaemia of anterior and posterior palatine arches, enlarged submandibular lymph nodes, halitosis, chronic sore throat, foreign body sensation or a history of expelling foul-tasting and foul smelling cheesy lumps. 5. Literate parents/guardian; ability to read English/Bengali. 6. Parents giving writing consent to participate.

Exclusion criteria

Exclusion criteria: 1. Patient with complication of tonsillitis like peritonsillar abcess and parapharyngeal abscess and infection, cor pulomonale. 2. Patient with uncontrolled systemic diseases, infection. 3. Children presenting with cranio-facial abnormalities and neurological disorders. 4. Diagnosed or suspected cases of tonsillar malignancy. 5. Patients already undergoing any treatment for tonsillitis [subject to enrolment after a wash-out phase of 15 days subjected to persistence of complaints] 6. Immune compromised patients. 7. Substance abuse and/or dependence.

Design outcomes

Primary

MeasureTime frame
Obstructive sleep apnoea questionnaire(OSD-6) measures quality of life in childrenTimepoint: At baseline, and after 6 and 12 weeks

Secondary

MeasureTime frame
Paediatric Quality of Life Inventory (PedsQL) questionnaire measuring quality of life in childrenTimepoint: At baseline, and after 6 and 12 weeks

Countries

India

Contacts

Public ContactGautam Ash

National Institute of Homoeopathy

dr.gautam.ash01@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026